Dr Ashley McCulloch
- Research Assistant (Clinical Research Garscube)
email:
Ashley.K.McCulloch@glasgow.ac.uk
pronouns:
She/her/hers
Publications
2025
Hillson, L. V.S. et al. (2025) Differential immunological effects of short-course and long-course radiotherapy in locally advanced rectal cancer. Clinical Cancer Research, (Accepted for Publication)
Berardi, D. et al. (2025) Senescence cell induction methods display diverse metabolic reprogramming and reveal an underpinning serine/taurine reductive metabolic phenotype. Aging Cell, 24(8), e70127. (doi: 10.1111/acel.70127) (PMID:40530891)
Woraharn, W. et al. (2025) Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer. Journal of Pathology: Clinical Research, 11(3), e70031. (doi: 10.1002/2056-4538.70031)
Craig, Rachel ORCID: https://orcid.org/0000-0001-8929-7055, McIntosh, Kathryn, Ho Ho, Ka, McCulloch, Ashley, Riley, Christopher, Lawson, Christopher, Mackay, Simon P., Paul, Andrew, Coats, Paul and Plevin, Robin
(2025)
IL-1β stimulates a novel axis within the NFκB pathway in endothelial cells regulated by IKKα and TAK-1.
Biochemical Pharmacology, 232,
116736.
(doi: 10.1016/j.bcp.2024.116736)
(PMID:39710275)
2024
Hillson, Lily Victoria Sarah, McCulloch, Ashley Kathryn, Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906, Dunne, Philip David, O'Cathail, Sean Michael
ORCID: https://orcid.org/0000-0001-5574-9199 and Roxburgh, Campbell Stuart
ORCID: https://orcid.org/0000-0002-2649-6695
(2024)
Radiation-induced changes in gene expression in rectal cancer specimens.
Clinical and Translational Oncology, 26(6),
pp. 1419-1428.
(doi: 10.1007/s12094-023-03361-9)
(PMID:38243085)
(PMCID:PMC11108951)
2023
Beach, C. et al. (2023) Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. Journal of Clinical Investigation, 133(23), e168277. (doi: 10.1172/JCI168277) (PMID:37824211) (PMCID:PMC10688992)
McIntosh, K. et al. (2023) IL-1β stimulates a novel, IKKα -dependent, NIK -independent activation of non-canonical NFκB signalling. Cellular Signalling, 107, 110684. (doi: 10.1016/j.cellsig.2023.110684) (PMID:37080443)
2020
McAllister, Milly J., McCall, Pamela, Dickson, Ashley, Underwood, Mark A., Andersen, Ditte, Holmes, Elizabeth, Market, Elke, Leung, Hing Y. ORCID: https://orcid.org/0000-0002-3933-3975 and Edwards, Joanne
ORCID: https://orcid.org/0000-0002-7192-6906
(2020)
Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer.
Prostate Cancer and Prostatic Diseases, 23(4),
pp. 596-606.
(doi: 10.1038/s41391-020-0235-1)
(PMID:32358577)
2018
Roseweir, A. K. et al. (2018) Predictive biomarkers for endocrine therapy: retrospective study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial. Journal of the National Cancer Institute, 110(6), pp. 616-627. (doi: 10.1093/jnci/djx255) (PMID:29917140)
Campbell, K. J. et al. (2018) MCL-1 is a prognostic indicator and drug target in breast cancer. Cell Death and Disease, 9, 19. (doi: 10.1038/s41419-017-0035-2) (PMID:29339815) (PMCID:PMC5833338)
2017
Cheng, Kelvin K.W., Dickson, Ashley, Gujam, Fadia J.A., McMillan, Donald C. ORCID: https://orcid.org/0000-0003-4260-5334 and Edwards, Joanne
ORCID: https://orcid.org/0000-0002-7192-6906
(2017)
The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer.
Histopathology, 70(5),
pp. 782-797.
(doi: 10.1111/his.13134)
(PMID:27891654)
Articles
Hillson, L. V.S. et al. (2025) Differential immunological effects of short-course and long-course radiotherapy in locally advanced rectal cancer. Clinical Cancer Research, (Accepted for Publication)
Berardi, D. et al. (2025) Senescence cell induction methods display diverse metabolic reprogramming and reveal an underpinning serine/taurine reductive metabolic phenotype. Aging Cell, 24(8), e70127. (doi: 10.1111/acel.70127) (PMID:40530891)
Woraharn, W. et al. (2025) Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer. Journal of Pathology: Clinical Research, 11(3), e70031. (doi: 10.1002/2056-4538.70031)
Craig, Rachel ORCID: https://orcid.org/0000-0001-8929-7055, McIntosh, Kathryn, Ho Ho, Ka, McCulloch, Ashley, Riley, Christopher, Lawson, Christopher, Mackay, Simon P., Paul, Andrew, Coats, Paul and Plevin, Robin
(2025)
IL-1β stimulates a novel axis within the NFκB pathway in endothelial cells regulated by IKKα and TAK-1.
Biochemical Pharmacology, 232,
116736.
(doi: 10.1016/j.bcp.2024.116736)
(PMID:39710275)
Hillson, Lily Victoria Sarah, McCulloch, Ashley Kathryn, Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906, Dunne, Philip David, O'Cathail, Sean Michael
ORCID: https://orcid.org/0000-0001-5574-9199 and Roxburgh, Campbell Stuart
ORCID: https://orcid.org/0000-0002-2649-6695
(2024)
Radiation-induced changes in gene expression in rectal cancer specimens.
Clinical and Translational Oncology, 26(6),
pp. 1419-1428.
(doi: 10.1007/s12094-023-03361-9)
(PMID:38243085)
(PMCID:PMC11108951)
Beach, C. et al. (2023) Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. Journal of Clinical Investigation, 133(23), e168277. (doi: 10.1172/JCI168277) (PMID:37824211) (PMCID:PMC10688992)
McIntosh, K. et al. (2023) IL-1β stimulates a novel, IKKα -dependent, NIK -independent activation of non-canonical NFκB signalling. Cellular Signalling, 107, 110684. (doi: 10.1016/j.cellsig.2023.110684) (PMID:37080443)
McAllister, Milly J., McCall, Pamela, Dickson, Ashley, Underwood, Mark A., Andersen, Ditte, Holmes, Elizabeth, Market, Elke, Leung, Hing Y. ORCID: https://orcid.org/0000-0002-3933-3975 and Edwards, Joanne
ORCID: https://orcid.org/0000-0002-7192-6906
(2020)
Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer.
Prostate Cancer and Prostatic Diseases, 23(4),
pp. 596-606.
(doi: 10.1038/s41391-020-0235-1)
(PMID:32358577)
Roseweir, A. K. et al. (2018) Predictive biomarkers for endocrine therapy: retrospective study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial. Journal of the National Cancer Institute, 110(6), pp. 616-627. (doi: 10.1093/jnci/djx255) (PMID:29917140)
Campbell, K. J. et al. (2018) MCL-1 is a prognostic indicator and drug target in breast cancer. Cell Death and Disease, 9, 19. (doi: 10.1038/s41419-017-0035-2) (PMID:29339815) (PMCID:PMC5833338)
Cheng, Kelvin K.W., Dickson, Ashley, Gujam, Fadia J.A., McMillan, Donald C. ORCID: https://orcid.org/0000-0003-4260-5334 and Edwards, Joanne
ORCID: https://orcid.org/0000-0002-7192-6906
(2017)
The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer.
Histopathology, 70(5),
pp. 782-797.
(doi: 10.1111/his.13134)
(PMID:27891654)